A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published
For proliferation assays, cells (5 10 4 per well) were plated in six-well plates with medium replacement every 48 h, followed by hemocytometer counting
If the promise indicated by certain studies on its anti-aging properties prove to be true, however, this synthetic peptide may become a household name
Nierenerkrankte: Bei eingeschrnkter Nierenfunktion kann die krpereigene Carnitin-Synthese gestrt sein
Specifically, accurate measurements were taken at precise intervals of 15, 30, 45 min, 1 h, 5 h, and one day after adding the working solution
Fizzah Iftikhar, orcid.org/0009-0006-9380-632X